Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | protein kinase, putative | 0.0033 | 0.0765 | 0.0765 |
Schistosoma mansoni | phosphatidylinositol 3-and 4-kinase | 0.0061 | 0.2511 | 0.2416 |
Echinococcus granulosus | FKBP12 rapamycin complex associated protein | 0.0182 | 1 | 1 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor2 | 0.0182 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0037 | 0.1029 | 0.0904 |
Echinococcus multilocularis | serine protein kinase ATM | 0.0034 | 0.0864 | 0.0864 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0155 | 0.8352 | 0.833 |
Trypanosoma cruzi | Protein kinase B | 0.0023 | 0.0125 | 0.0125 |
Trypanosoma brucei | target of rapamycin kinase 3, putative | 0.0145 | 0.7704 | 0.7514 |
Trypanosoma brucei | phosphatidylinositol 3-kinase tor, putative | 0.0086 | 0.4061 | 0.3569 |
Trypanosoma brucei | Phosphatidylinositol 3-kinase tor1 | 0.0182 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0182 | 1 | 1 |
Trypanosoma cruzi | rac serine-threonine kinase, putative | 0.0023 | 0.0125 | 0.0125 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0135 | 0.7113 | 0.7073 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.0864 | 0.0737 |
Schistosoma mansoni | fkbp-rapamycin associated protein | 0.0034 | 0.0864 | 0.0747 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0182 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0098 | 0.4817 | 0.4745 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0135 | 0.7113 | 0.7073 |
Brugia malayi | p70 ribosomal S6 kinase beta | 0.0031 | 0.0639 | 0.027 |
Entamoeba histolytica | hypothetical protein | 0.0034 | 0.0864 | 0.0864 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0145 | 0.7695 | 0.7663 |
Trichomonas vaginalis | AGC family protein kinase | 0.0033 | 0.0765 | 0.0637 |
Trypanosoma brucei | phosphatidylinositol 3-related kinase, putative | 0.0061 | 0.2511 | 0.1891 |
Echinococcus granulosus | serine:threonine protein kinase SMG1 | 0.0034 | 0.0864 | 0.0864 |
Loa Loa (eye worm) | AGC/AKT protein kinase | 0.0033 | 0.0765 | 0.0637 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0145 | 0.7695 | 0.7663 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0098 | 0.4807 | 0.4735 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0135 | 0.7113 | 0.7073 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0122 | 0.629 | 0.6239 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0098 | 0.4817 | 0.4745 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0108 | 0.5398 | 0.5335 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0135 | 0.7113 | 0.7073 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0109 | 0.5465 | 0.5402 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0038 | 0.1107 | 0.0984 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0135 | 0.7113 | 0.7073 |
Brugia malayi | Protein kinase domain containing protein | 0.0033 | 0.0765 | 0.04 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0034 | 0.0864 | 0.0737 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.038 | 0.0247 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0118 | 0.6047 | 0.5992 |
Plasmodium falciparum | RAC-beta serine/threonine protein kinase | 0.002 | 0 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0061 | 0.2511 | 0.2407 |
Entamoeba histolytica | protein kinase, putative | 0.0033 | 0.0765 | 0.0765 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0135 | 0.7113 | 0.7073 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0061 | 0.2511 | 0.2215 |
Entamoeba histolytica | FKBP-rapamycin associated protein (FRAP), putative | 0.0182 | 1 | 1 |
Trypanosoma brucei | phosphatidylinositol kinase related protein, putative | 0.0034 | 0.0864 | 0.0107 |
Entamoeba histolytica | PH domain containing protein kinase, putative | 0.0023 | 0.0125 | 0.0125 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0061 | 0.2511 | 0.2407 |
Trichomonas vaginalis | AGC family protein kinase | 0.0033 | 0.0765 | 0.0637 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0034 | 0.0864 | 0.0503 |
Entamoeba histolytica | phosphatidylinositol3-kinaseTor2, putative | 0.0182 | 1 | 1 |
Trypanosoma cruzi | phosphatidylinositol kinase related protein, putative | 0.0023 | 0.0137 | 0.0137 |
Schistosoma mansoni | ataxia telangiectasia mutated (atm)-related | 0.0182 | 1 | 1 |
Toxoplasma gondii | non-specific serine/threonine protein kinase | 0.0038 | 0.1107 | 0.0722 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0145 | 0.7695 | 0.7663 |
Leishmania major | target of rapamycin (TOR) kinase 2, putative | 0.0182 | 1 | 1 |
Trypanosoma brucei | FAT domain/Rapamycin binding domain/Phosphatidylinositol 3- and 4-kinase, putative | 0.0076 | 0.3412 | 0.2867 |
Echinococcus multilocularis | FKBP12 rapamycin complex associated protein | 0.0182 | 1 | 1 |
Toxoplasma gondii | FATC domain-containing protein | 0.0034 | 0.0864 | 0.0346 |
Trichomonas vaginalis | AGC family protein kinase | 0.0033 | 0.0765 | 0.0637 |
Trypanosoma cruzi | phosphatidylinositol kinase related protein, putative | 0.0034 | 0.0864 | 0.0864 |
Trypanosoma cruzi | phosphatidylinositol 3-related kinase, putative | 0.0061 | 0.2511 | 0.2511 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0061 | 0.2511 | 0.2407 |
Trypanosoma brucei | phosphatidylinositol 3-kinase, putative | 0.0061 | 0.2511 | 0.1891 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0109 | 0.5465 | 0.5402 |
Echinococcus multilocularis | phosphatidylinositol 3 and 4 kinase | 0.0061 | 0.2511 | 0.2511 |
Giardia lamblia | GTOR | 0.0182 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0182 | 1 | 1 |
Entamoeba histolytica | Phosphatidylinositol 3- and 4-kinase family | 0.0034 | 0.0864 | 0.0864 |
Entamoeba histolytica | protein kinase, putative | 0.0031 | 0.0639 | 0.0639 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0034 | 0.0864 | 0.0737 |
Trypanosoma cruzi | target of rapamycin kinase 3 | 0.0145 | 0.7704 | 0.7704 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0049 | 0.1756 | 0.1641 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor1 | 0.0182 | 1 | 1 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0034 | 0.0864 | 0.0503 |
Leishmania major | target of rapamycin (TOR) kinase 1, putative | 0.0182 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0061 | 0.2511 | 0.2407 |
Trypanosoma cruzi | phosphatidylinositol 3-related kinase, putative | 0.0061 | 0.2511 | 0.2511 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0061 | 0.2511 | 0.2407 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0061 | 0.2511 | 0.2407 |
Trichomonas vaginalis | AGC family protein kinase | 0.0033 | 0.0765 | 0.0637 |
Schistosoma mansoni | ataxia telangiectasia mutated (atm) | 0.0034 | 0.0864 | 0.0747 |
Echinococcus multilocularis | serine:threonine protein kinase SMG1 | 0.0034 | 0.0864 | 0.0864 |
Schistosoma mansoni | hypothetical protein | 0.0027 | 0.038 | 0.0258 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0145 | 0.7695 | 0.7663 |
Entamoeba histolytica | PH domain containing protein kinase, putative | 0.0023 | 0.0125 | 0.0125 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0034 | 0.0864 | 0.0737 |
Trichomonas vaginalis | AGC family protein kinase | 0.0033 | 0.0765 | 0.0637 |
Toxoplasma gondii | target of rapamycin (TOR), putative | 0.0135 | 0.7113 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0027 | 0.038 | 0.0247 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0098 | 0.4807 | 0.4735 |
Trypanosoma cruzi | phosphatidylinositol 3-kinase, putative | 0.0034 | 0.0864 | 0.0864 |
Trypanosoma brucei | phosphatidylinositol 4-kinase, putative | 0.0182 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0135 | 0.7113 | 0.7073 |
Echinococcus granulosus | serine/threonine protein kinase | 0.0023 | 0.0125 | 0.0125 |
Echinococcus granulosus | PIK kinase FAT and Armadillo domain containing protein | 0.0027 | 0.038 | 0.038 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0108 | 0.5398 | 0.5335 |
Loa Loa (eye worm) | hypothetical protein | 0.0038 | 0.1107 | 0.0984 |
Echinococcus granulosus | phosphatidylinositol 3 and 4 kinase | 0.0061 | 0.2511 | 0.2511 |
Plasmodium vivax | rac-beta serine/threonine protein kinase, putative | 0.002 | 0 | 0.5 |
Echinococcus granulosus | serine protein kinase ATM | 0.0034 | 0.0864 | 0.0864 |
Echinococcus multilocularis | PIK kinase, FAT and Armadillo domain containing protein | 0.0027 | 0.038 | 0.038 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0098 | 0.4817 | 0.4745 |
Entamoeba histolytica | protein kinase rad3, putative | 0.0034 | 0.0864 | 0.0864 |
Trichomonas vaginalis | AGC family protein kinase | 0.0033 | 0.0765 | 0.0637 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0098 | 0.4807 | 0.4735 |
Trichomonas vaginalis | AGC family protein kinase | 0.0033 | 0.0765 | 0.0637 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0109 | 0.5465 | 0.5402 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0182 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0145 | 0.7695 | 0.7663 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0098 | 0.4817 | 0.4745 |
Leishmania major | target of rapamycin kinase (TOR) kinase 3 | 0.0145 | 0.7704 | 0.6934 |
Echinococcus multilocularis | rac serine:threonine kinase | 0.0023 | 0.0125 | 0.0125 |
Loa Loa (eye worm) | AGC/RSK/P70 protein kinase | 0.0031 | 0.0639 | 0.051 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.